Skip to main content

ENTRESTO® supports your eligible heart failure patients with options to help them start and stay on treatment as prescribed

$10 Co-Pay Card for eligible commercially insured patients

$10 CO-PAY OFFER FOR ELIGIBLE COMMERCIALLY INSURED PATIENTS

Eligible commercially insured patients may pay as little as $10 for up to a 90-day supply of ENTRESTO.

*In PARAGON-HF, defined as LVEF ≥45% with structural heart disease (LAE or LVH); median LVEF was 57%. LVEF is a variable measure and the normal range can vary.2
Limitations apply. See Program Terms and Conditions. Eligible commercial patients pay as little as a $10 co-pay for each prescription fill (30-, 60-, 90-day fill) at retail or mail order. The program pays up to a $4100 cap across all fills per calendar year. Patient will be responsible for any co-pay once the $4100 limit is reached in a calendar year. This offer is not valid under Medicare, Medicaid, or any other federal or state program. See full Terms and Conditions below.

Download additional patient resources below

View ENTRESTO clinical and biomarker data for HFrEF

See biomarker and echocardiographic data in HFrEF patients taking ENTRESTO

Learn how ENTRESTO impacted hospitalization in HFpEF patients with LVEF below normal* vs valsartan

Definitions
HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; LVEF, left ventricular ejection fraction.

References
1. Data on file. Novartis Pharmaceuticals Corp; 2022.
2. ENTRESTO [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corp.